دورية أكاديمية
أعرض في EDS

The Prevalence of Metallo-Beta-Lactamese-(MβL)-Producing Pseudomonas aeruginosa Isolates in Brazil: A Systematic Review and Meta-Analysis.

التفاصيل البيبلوغرافية
العنوان: The Prevalence of Metallo-Beta-Lactamese-(MβL)-Producing Pseudomonas aeruginosa Isolates in Brazil: A Systematic Review and Meta-Analysis.
المؤلفون: Dos Santos PAS; Program in Parasitic Biology in the Amazon Region (PPGBPA), State University of Pará (UEPA), Belém 66087-662, PA, Brazil.; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil., Silva MJA; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil.; Program in Epidemiology and Health Surveillance (PPGEVS), Evandro Chagas Institute (IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil., Gouveia MIM; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil., Lima LNGC; Program in Parasitic Biology in the Amazon Region (PPGBPA), State University of Pará (UEPA), Belém 66087-662, PA, Brazil.; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil.; Program in Epidemiology and Health Surveillance (PPGEVS), Evandro Chagas Institute (IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil., Quaresma AJPG; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil., De Lima PDL; Program in Parasitic Biology in the Amazon Region (PPGBPA), State University of Pará (UEPA), Belém 66087-662, PA, Brazil., Brasiliense DM; Program in Parasitic Biology in the Amazon Region (PPGBPA), State University of Pará (UEPA), Belém 66087-662, PA, Brazil.; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil.; Program in Epidemiology and Health Surveillance (PPGEVS), Evandro Chagas Institute (IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil., Lima KVB; Program in Parasitic Biology in the Amazon Region (PPGBPA), State University of Pará (UEPA), Belém 66087-662, PA, Brazil.; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil.; Program in Epidemiology and Health Surveillance (PPGEVS), Evandro Chagas Institute (IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil., Rodrigues YC; Bacteriology and Mycology Section, Evandro Chagas Institute (SABMI/IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil.; Program in Epidemiology and Health Surveillance (PPGEVS), Evandro Chagas Institute (IEC), Ministry of Health, Ananindeua 67030-000, PA, Brazil.; Department of Natural Science, State University of Pará (DCNA/UEPA), Belém 66050-540, PA, Brazil.
المصدر: Microorganisms [Microorganisms] 2023 Sep 21; Vol. 11 (9). Date of Electronic Publication: 2023 Sep 21.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101625893 Publication Model: Electronic Cited Medium: Print ISSN: 2076-2607 (Print) Linking ISSN: 20762607 NLM ISO Abbreviation: Microorganisms Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2013]-
مستخلص: The purpose of the current study is to describe the prevalence of Pseudomonas aeruginosa (PA)-producing MβL among Brazilian isolates and the frequency of bla SPM-1 in MβL-PA-producing isolates. From January 2009 to August 2023, we carried out an investigation on this subject in the internet databases SciELO, PubMed, Science Direct, and LILACS. A total of 20 papers that met the eligibility requirements were chosen by comprehensive meta-analysis software v2.2 for data retrieval and analysis by one meta-analysis using a fixed-effects model for the two investigations. The prevalence of MβL-producing P. aeruginosa was 35.8% or 0.358 (95% CI = 0.324-0.393). The studies' differences were significantly different from one another (x 2 = 243.15; p < 0.001; I 2 = 92.18%), so they were divided into subgroups based on Brazilian regions. There was indication of asymmetry in the meta-analyses' publishing bias funnel plot; so, a meta-regression was conducted by the study's publication year. According to the findings of Begg's test, no discernible publishing bias was found. bla SPM-1 prevalence was estimated at 66.9% or 0.669 in MβL-PA isolates (95% CI = 0.593-0.738). The analysis of this one showed an average heterogeneity (x 2 = 90.93; p < 0.001; I 2 = 80.20%). According to the results of Begg's test and a funnel plot, no discernible publishing bias was found. The research showed that MβL- P. aeruginosa and SPM-1 isolates were relatively common among individuals in Brazil. P. aeruginosa and other opportunistic bacteria are spreading quickly and causing severe infections, so efforts are needed to pinpoint risk factors, reservoirs, transmission pathways, and the origin of infection.
References: Antibiotics (Basel). 2022 Mar 21;11(3):. (PMID: 35326884)
Sci Total Environ. 2022 Dec 1;850:157975. (PMID: 35964754)
Trends Microbiol. 2011 Dec;19(12):588-95. (PMID: 22078325)
J Infect Public Health. 2021 May;14(5):628-637. (PMID: 33848892)
Antimicrob Agents Chemother. 2010 Jan;54(1):582. (PMID: 19858251)
Clinics (Sao Paulo). 2010;65(9):825-9. (PMID: 21049207)
J Antimicrob Chemother. 2002 Nov;50(5):673-9. (PMID: 12407123)
J Glob Antimicrob Resist. 2019 Mar;16:92-97. (PMID: 30244038)
Yale J Biol Med. 2022 Dec 22;95(4):507-515. (PMID: 36568831)
Rev Chilena Infectol. 2021 Oct;38(5):724-726. (PMID: 35506843)
Chemotherapy. 2014;60(1):54-62. (PMID: 25402327)
J Med Microbiol. 2016 Jul;65(7):696-697. (PMID: 27126265)
Braz J Microbiol. 2017 Apr - Jun;48(2):211-217. (PMID: 28034598)
Chem Rev. 2021 Jul 14;121(13):7957-8094. (PMID: 34129337)
Res Microbiol. 2014 Dec;165(10):852-6. (PMID: 25445011)
Clin Microbiol Rev. 2013 Jul;26(3):361-80. (PMID: 23824364)
J Appl Microbiol. 2015 Jun;118(6):1276-86. (PMID: 25752460)
Int J Med Microbiol. 2014 May;304(3-4):405-14. (PMID: 24594145)
Front Public Health. 2023 Feb 09;11:1088262. (PMID: 36844819)
J Glob Antimicrob Resist. 2019 Dec;19:181-182. (PMID: 31542553)
Antimicrob Resist Infect Control. 2022 Jan 21;11(1):13. (PMID: 35063019)
Int J Evid Based Healthc. 2019 Mar;17(1):36-43. (PMID: 30239357)
Ann Intern Med. 1993 Apr 1;118(7):557-61. (PMID: 8442626)
Clin Microbiol Infect. 2003 Dec;9(12):1203-14. (PMID: 14686985)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
Rev Lat Am Enfermagem. 2007 May-Jun;15(3):508-11. (PMID: 17653438)
Clin Infect Dis. 2023 Jun 16;76(12):2059-2069. (PMID: 36801828)
Jundishapur J Microbiol. 2015 Apr 18;8(4):e17489. (PMID: 26034547)
J Med Microbiol. 2017 Dec;66(12):1722-1729. (PMID: 29095142)
Rev Soc Bras Med Trop. 2012 Dec;45(6):707-12. (PMID: 23295873)
Ther Adv Infect Dis. 2016 Feb;3(1):15-21. (PMID: 26862399)
Rev Soc Bras Med Trop. 2010 Jul-Aug;43(4):367-71. (PMID: 20802932)
Antimicrob Agents Chemother. 2013 Jan;57(1):410-6. (PMID: 23114762)
Microb Drug Resist. 2017 Sep;23(6):682-686. (PMID: 28085553)
PLoS One. 2020 Sep 10;15(9):e0238741. (PMID: 32911510)
Emerg Infect Dis. 2019 Jul;25(7):1281-1288. (PMID: 31211681)
Expert Rev Anti Infect Ther. 2021 Feb;19(2):197-213. (PMID: 32813566)
Microb Drug Resist. 2017 Apr;23(3):328-334. (PMID: 27326514)
Infez Med. 2020 Sep 1;28(3):314-321. (PMID: 32920566)
Rev Soc Bras Med Trop. 2009 Jul-Aug;42(4):411-4. (PMID: 19802477)
J Hosp Infect. 2014 Aug;87(4):234-40. (PMID: 25027563)
Biotechnol Adv. 2019 Jan - Feb;37(1):177-192. (PMID: 30500353)
Expert Rev Anti Infect Ther. 2017 Mar;15(3):277-297. (PMID: 27915487)
Chem Sci. 2015 Feb 19;6(2):956-963. (PMID: 25717359)
Infect Chemother. 2015 Jun;47(2):81-97. (PMID: 26157586)
Antimicrob Agents Chemother. 2010 Jul;54(7):3072. (PMID: 20421402)
J Lab Physicians. 2012 Jan;4(1):39-42. (PMID: 22923921)
J Mol Biol. 2006 Mar 31;357(3):890-903. (PMID: 16460758)
Med Sci (Basel). 2017 Dec 21;6(1):. (PMID: 29267233)
Rev Soc Bras Med Trop. 2016 May-Jun;49(3):305-11. (PMID: 27384827)
Rev Soc Bras Med Trop. 2010 Jul-Aug;43(4):462-4. (PMID: 20802952)
Infection. 2007 Dec;35(6):457-60. (PMID: 18034208)
Rev Soc Bras Med Trop. 2010 Jul-Aug;43(4):372-6. (PMID: 20802933)
Microorganisms. 2023 Aug 11;11(8):. (PMID: 37630629)
Emerg Microbes Infect. 2022 Dec;11(1):811-814. (PMID: 35240944)
Antimicrob Agents Chemother. 2013 Oct;57(10):5162-5. (PMID: 23877696)
J Glob Infect Dis. 2018 Oct-Dec;10(4):212-217. (PMID: 30581263)
Infect Genet Evol. 2019 Sep;73:411-415. (PMID: 31121306)
Antimicrob Agents Chemother. 1991 Jan;35(1):147-51. (PMID: 1901695)
Diagn Microbiol Infect Dis. 2008 Jan;60(1):125-8. (PMID: 17900848)
Iran J Microbiol. 2015 Feb;7(1):2-6. (PMID: 26644866)
Mem Inst Oswaldo Cruz. 2016 Sep;111(9):551-8. (PMID: 27653359)
Lancet Planet Health. 2023 Apr;7(4):e291-e303. (PMID: 37019570)
Microb Drug Resist. 2017 Oct;23(7):852-863. (PMID: 28437232)
Braz J Infect Dis. 2011 Sep-Oct;15(5):478-81. (PMID: 22230856)
Lancet Planet Health. 2018 Sep;2(9):e398-e405. (PMID: 30177008)
Lancet Infect Dis. 2018 Mar;18(3):318-327. (PMID: 29276051)
Curr Microbiol. 2022 Apr 30;79(6):175. (PMID: 35488983)
Lancet Infect Dis. 2013 Oct;13(10):867-76. (PMID: 23845533)
Diagn Microbiol Infect Dis. 2018 Mar;90(3):221-227. (PMID: 29224710)
mSystems. 2020 Nov 24;5(6):. (PMID: 33234606)
Iran J Pathol. 2018 Winter;13(1):1-9. (PMID: 29731790)
Drug Resist Updat. 2014 Apr;17(1-2):24-36. (PMID: 24618111)
BMC Genomics. 2020 Mar 23;21(1):255. (PMID: 32293244)
Infect Drug Resist. 2023 Jan 19;16:337-346. (PMID: 36698726)
Antimicrob Resist Infect Control. 2023 Apr 3;12(1):28. (PMID: 37013661)
J Am Board Fam Med. 2007 Nov-Dec;20(6):533-9. (PMID: 17954860)
Antimicrob Agents Chemother. 2003 Feb;47(2):582-7. (PMID: 12543663)
Antibiotics (Basel). 2023 Jan 11;12(1):. (PMID: 36671350)
J Antimicrob Chemother. 2015 Sep;70(9):2547-50. (PMID: 26093374)
J Antimicrob Chemother. 2014 Jul;69(7):1804-14. (PMID: 24603963)
J Glob Antimicrob Resist. 2020 Dec;23:55-63. (PMID: 32858259)
Rev Soc Bras Med Trop. 2018 Jul-Aug;51(4):415-420. (PMID: 30133622)
Future Sci OA. 2020 Jan 27;6(3):FSO438. (PMID: 32140243)
Emerg Infect Dis. 2018 Jun;24(6):1160-1162. (PMID: 29774849)
BMC Infect Dis. 2012 Aug 03;12:176. (PMID: 22863113)
Pathology. 2015 Apr;47(3):276-84. (PMID: 25764207)
Front Microbiol. 2021 Feb 18;12:614058. (PMID: 33679638)
Mem Inst Oswaldo Cruz. 2012 May;107(3):420-3. (PMID: 22510840)
J Hosp Infect. 2021 Sep;115:83-92. (PMID: 34033889)
Rev Soc Bras Med Trop. 2008 May-Jun;41(3):306-8. (PMID: 18719815)
فهرسة مساهمة: Keywords: Brazil; MΒL; Pseudomonas aeruginosa; blaSPM-1; meta-analysis
تواريخ الأحداث: Date Created: 20230928 Latest Revision: 20231003
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10534863
DOI: 10.3390/microorganisms11092366
PMID: 37764210
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-2607
DOI:10.3390/microorganisms11092366